Abstracts and Education
Call for Abstracts
Submission deadline:
May 2, 2013
Download
the Call for Abstracts.
Abstract notices will be sent in late August.
Late Breaker Abstracts
Submission deadline: August 21,
2013
The late breaker abstract submission site will open in
early July.
Download
the Call for Abstracts.
Late breaker abstract notices will be sent in late October.
Call for Symposia
Submission Deadline: March 5, 2013
Download
the symposium submission guidelines.
Symposium notices will be sent in early May.
Pre-Meeting Courses
Basic Science Pre Meeting Course
Wednesday,
November 13, 2013
7:30 am – 4 pm
The Future of Experimental Genetics: New Approaches to Generating
Transgenic Parasites
Co-chairs: Oliver Billker, PhD,
David Fidock, PhD, Julian Rayner, PhD
Download
Tentative Agenda
Over the past two decades experimental genetic techniques have revolutionized our understanding of pathogenic human parasites, yielding major biological insights and identifying new therapeutic targets. While these approaches have been very useful, they have clear limitations in many parasite systems. Scale and throughput are frequent hurdles, with studies of a dozen genes consuming a large investment of time and resources, yet not making a significant impact in deciphering those genomes containing thousands of genes. The robustness of available tools is also a major issue, with essentiality often being inferred from the repeated failure of standard knockout approaches, rather than being proven directly by using regulated expression systems in which genes can be switched on or off in a short time scale.
A number of recent and significant advances in transgenic technology
now offer the potential to overcome these limitations, and move parasite
experimental genetic studies towards the whole-genome scale. This course
will communicate the latest technological advances in parasite
experimental genetics, including both targeted approaches such as
customized zinc-finger nucleases and RNA interference, and
non-sequence-specific approaches such as transposon mutagenesis. In this
course, we will cover a wide range of parasite systems and explore the
key issues of scalability and genetically-regulatable technologies. The
course will include both formal lectures and interactive discussion
groups, with the overall goals of sharing the very latest advances in
parasite experimental genetics and discussing the opportunities that
these technologies create.
Clinical Pre-Meeting Course
Tuesday, November
12, 2013, 1 – 5 pm
Wednesday, November 13, 2013, 7:30 am – 3 pm
Illness in and from the Tropics – Learning from Endemic
and Imported Disease
Co-chairs: Timothy Endy, MD, MPH
and Michael Libman, MD
Download
Tentative Agenda
This 1.5-day course will target tropical medicine practitioners, infectious disease consultants, epidemiologists, clinical microbiologists, graduate students, public health physicians, medical educators and other health care professionals with an interest in clinical tropical medicine. This course will be an audience participation-based case-series of challenging clinical questions from the tropics covering major diagnostic and therapeutic challenges that clinicians face in the returning traveler or immigrant from overseas. A panel of expert speakers will discuss the diagnosis, management and clinical approaches of tropical viral infections, tropical dermatology, filariasis, malaria, leishmaniasis, traveler’s diarrhea and other travel related issues and vaccines.
Global Health Pre-Meeting Course
Wednesday,
November 13, 2013
8:00 am – 3 pm
Multi-Disciplinary Approaches to Detect Analyze and Control
Substandard and Falsified Medical Interventions
Co-chairs: Christopher Perdue, MD, MPH and Katherine
Taylor, PhD
Download
Tentative Agenda
This course will explore the impact of poor quality medical
interventions on country and global health programs and research. Health
practitioners, researchers, policy-makers, regulators, and public and
private health institutions need to be aware of the possibility of low
quality, falsified or contaminated drugs and other medical interventions
in their supply chain and the negative impact those may have on program
objectives and the health of the populations they serve. As the global
manufacturing base for health-related products has increased –
driven by the emergence of a “global health enterprise,” new
economies, and a global supply network – national and
international regulations have proven incapable of ensuring the quality
of production and supply. Few resources are available in most
settings to determine the authenticity, safety and efficacy of medical
materiel on-hand. Poor quality medical interventions include
drugs, vaccines, diagnostics and vector control products that are
ineffective or unsafe because of poor production, improper storage or
transportation, or intentional falsification or mislabeling. A panel of
experts will address what we know about the problem and its impact, as
well as identify the key gaps in our knowledge. Participants and members
of the expert panel will discuss the opportunities to: a) integrate
issues related to poor quality medical interventions into global health
programs; b) implement and share solutions across the global health
enterprise; c) identify institutions or organizations best-placed to
fill knowledge gaps; and d) promote partnerships to minimize the impact
of poor quality medical intervention on global health.